Global Migraine Market By Therapeutic Use (Acute, Preventive) By Therapeutic Class (CGRP monoclonal antibodies, CGRP small molecule antagonists, Acetylcholine inhibitors/ neurotoxins, Triptans, Ditans, Ergot alkaloids, NSAIDs, Others) By Route of Administration (Oral, Injectable, Others) By Age Group (Pediatric, Adult, Geriatric) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Oct 2025
- Report ID: 160977
- Number of Pages: 257
- Format:
-
keyboard_arrow_up
-
-
- Eli Lilly
- Teva Pharmaceutical Industries
- GlaxoSmithKline (GSK)
- Pfizer
- AbbVie
- Allergan
- Merck & Co.
- Sanofi
- Bausch Health
- Biohaven
- Axsome Therapeutics
- Theranica
- Medtronic
- eNeura
- Cefaly Technology
- Other key players
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible